Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Nanome logo — Scaling Humanity

Nanome

Scaling Humanity

Founded 2015 United States San Diego, United States 19 employees Series A Total: $4.70M AI, Biopharma +3

General Information

Company Name Nanome
Founded Year 2015
Location United States San Diego, United States
Founders / Decision Makers
Team member
Employees 19
Industries AI, Biopharma, Biotechnology +2
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Nanome. To contact Nanome, visit nanome.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nanome compare?

A PDF of Nanome and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nanome soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nanome

Nanome, founded in 2015, revolutionizes scientific discovery through its immersive virtual reality (VR) platform. Dubbed the "ultimate interface" for molecular data, it facilitates top-tier research, empowering R&D labs to make significant, billion-dollar decisions. Enthusiasts—from professional scientists to students—leverage Nanome to build intricate 3D molecules and simulate entire proteins within a collaborative environment.

Deployed on devices like the Meta Quest Pro, Nanome intertwines education with innovation, enhancing the user experience in AI, Biopharma, Biotechnology, and VR/AR sectors. The company is headquartered in the United States, and it secured a Series A investment on 01 August 2022, backed by Navigate Ventures, LLC. This investment serves as a testament to its growth potential in transforming molecular education and research.

Business keywords: Collaborative XR Software, Molecular Data, 3D Molecule Building, Protein Simulation, Scientific Discovery, Biopharma Industry, Computational Workflows, AI in Molecular Computation, Material Science, Virtual Reality, STEM Education, Bio-Technology, Data Visualization, Data Exploration, Protein Design

Services & Products

Collaborative molecular visualization
Drug discovery platform
Real-time multiplayer sessions
XR integration for molecular analysis
AI-Enhanced molecular structuring

Target Customers

R&D Teams Pharmaceutical Companies Scientific Researchers Biotech Startups University Labs

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 1
Navigate Ventures
Navigate Ventures
01 Aug 2022
Early VC $3.00M 2
Bullpen Capital Formic Ventures
Bullpen Capital, Formic Ventures
01 Feb 2021
Seed $1.70M -
01 Aug 2017
Seed Undisclosed -
01 Mar 2017
Spinout Undisclosed 1
University Ventures
University Ventures
01 Aug 2015

Nanome Alternatives & Competitors

View All Alternatives
Nanome vs
Fathom Therapeutics
Fathom Therapeutics United States

The molecular frontier

Seed
22 employees
Biopharma, Biotechnology
Nanome vs
iktos
iktos France

Artificial intelligence for new drug design

Series A
85 employees
AI, Biotechnology
Nanome vs
PharmCADD
PharmCADD Korea South

PharmCADD is a company designed to accelerate drug discovery using technologies of AI and Molecular...

Series B
16 employees
AI, Biotechnology
View all alternatives

FAQ About Nanome

Scaling Humanity
Nanome was founded in 2015.
Nanome is headquartered in San Diego, United States.
Nanome operates in AI, Biopharma, Biotechnology, Education and VR/AR. Its work centres on Collaborative XR Software, Molecular Data, 3D Molecule Building and Protein Simulation. Its customers include R&D Teams, Pharmaceutical Companies and Scientific Researchers.
Nanome has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Nanome has approximately 19 employees.
Nanome has completed 5 funding rounds, raising a total of $4.70M. The latest funding stage is Series A.
Nanome offers: Collaborative molecular visualization, Drug discovery platform, Real-time multiplayer sessions, XR integration for molecular analysis, AI-Enhanced molecular structuring.
Top alternatives and competitors to Nanome include Fathom Therapeutics, iktos, PharmCADD, clear_pixel VR, Majecules LLC.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanome and Fathom Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nanome, https://bouncewatch.com/company/nanome, updated 23 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes